English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 850410      Online Users : 987
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8627


    Title: Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets
    Authors: Chia, MY;Hu, AY;Tseng, YF;Weng, TC;Lai, CC;Lin, JY;Chen, PL;Wang, YF;Chao, SR;Chang, JY;Hwang, YS;Yeh, CT;Yu, CP;Chen, YC;Su, IJ;Lee, MS
    Contributors: Division of Infectious Diseases;Division of Vaccine Research and Development
    Abstract: Avian-origin influenza A (H7N9) viruses emerged as human pathogens in China in early 2013 and have killed >100 persons. Influenza vaccines are mainly manufactured using egg-based technology which could not meet the surging demand during influenza pandemics. In this study, we evaluated cell-based influenza H7N9 vaccines in ferrets. An egg-derived influenza H7N9 reassortant vaccine virus was adapted in MDCK cells. Influenza H7N9 whole virus vaccine antigen was manufactured using a microcarrier-based culture system. Immunogenicity and protection of the vaccine candidates with three different formulations (300mug aluminum hydroxide, 1.5mug HA, and 1.5mug HA plus 300mug aluminum hydroxide) were evaluated in ferrets. In ferrets receiving two doses of vaccination, geometric mean titers of hemagglutination (HA) inhibition and neutralizing antibodies were <10 and <40 for the control group (adjuvant only), 17 and 80 for the unadjuvanted (HA only) group, and 190 and 640 for the adjuvanted group (HA plus adjuvant), respectively. After challenge with wild-type influenza H7N9 viruses, virus titers in respiratory tracts of the adjuvanted group were significantly lower than that in the control, and unadjuvanted groups. MDCK cell-derived influenza H7N9 whole virus vaccine candidate is immunogenic and protective in ferrets and clinical development is highly warranted.
    Date: 2015-03-23
    Relation: PLoS ONE. 2015 Mar 23;10(3):Article number e0120793.
    Link to: http://dx.doi.org/10.1371/journal.pone.0120793
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1932-6203&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000351987300178
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84925813058
    Appears in Collections:[李敏西] 期刊論文
    [蘇益仁(2002-2015)] 期刊論文
    [陳宜君] 期刊論文
    [胡勇誌] 期刊論文

    Files in This Item:

    File Description SizeFormat
    PUB25799397.pdf3017KbAdobe PDF730View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback